03/01/2013
4th Annual GNF-JDRF Diabetes Research Symposium
When: April 18, 2013
Time: 8:30 AM – 5 PM
Where: The Genomic Institute of the Novartis Foundation (GNF), San Diego, CA
Hosted by: Martin Seidel (GNF) and Richard Insel (JDRF)
Title: New Frontiers in Beta Cell Biology
Invited Speakers and Registration Form: see poster here
Registration required; space is limited.
02/07/2013
JDRF Requests for Applications (RFA): JDRF Clinical Investigator Training Awards in the Treatment of Type 1 Diabetes. More details.
12/19/2012
NIDDK has launched a new RFA. “Bioengineering Interdisciplinary Training for Diabetes Research (T32)” More details.
12/19/2012
NIDDK has launched a new RFA. “Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas.” More details.
12/11/2012
JDRF Requests for Applications (RFA): Studies Relevant to the Discovery and Development of Antigen Specific Therapies for Human Type 1 Diabetes. More details.
12/04/2012
JDRF Request for Applications (RFA): Training Travel Awards. More details.
11/30/2012
Notice of Correction Regarding Resubmissions and Budget Instructions for NIDDK PAR-13-013 “Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3)” More information.
11/30/2012
Research Using Subjects From Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3) . More information
11/30/2012
Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3) More information
11/29/2012
JDRF Request for Applications (RFA): Studies Relevant to the Prevention of Human Type 1 Diabetes. More information
11/26/2012
JDRF Request for Applications (RFA): Fault Detection Algorithms for Risk Mitigation in Artificial Pancreas Systems: More information.
11/26/2012
JDRF Request for Applications (RFA): Insulin Sensor Initiative. More information.
11/26/2012
JDRF Request for Applications (RFA): JDRF Autoimmunity and Beta Cell Cure and Prevention Translational Centers. More information.
10/1/2012
JDRF Request for Applications (RFA): Biologic Factors and Targets for Promoting Beta Cell Regeneration, Health, and Survival: More information
8/27/2012
Established T1D Clinical Research Roadmap, Paving a New Path; A White Paper sponsored by JDRF and The Helmsley Charitable Trust. Several factors have caused a shortfall in established type 1 diabetes (T1D) non-insulin clinical research, despite the fact that T1D is one of the more prevalent autoimmune diseases. New, emerging data could challenge the current thinking surrounding the potential for therapeutic interventions in people with established T1D. Based on these findings, a bolder approach to clinical research in people with established T1D is clearly warranted. Near-term clinical development opportunities in established T1D subjects are evident. Download the report.
8/23/2012
JDRF Request for Information (RFI): Biomarkers of Pancreatic Beta Cell Stress and Health Non-Competitive Consortium: More information
7/17/2012
JDRF Symposium at EASD – Final Agenda
7/03/2012
The 20th International Conference on Bioencapsulation will take place on 9/20-24, 2012. There is an Islet Encapsulation Focus Session. Details on the Islet Encapsulation Focus Session can be found here.
6/12/2012
JDRF Mourns the Loss of Dr. Alan Permutt
JDRF is saddened by the loss of a long-time advocate, friend, and inspiring researcher, M. Alan Permutt, MD, who passed away at the age of 72 on Sunday, June 10th after a long battle with cancer. More information.
1/31/2012
12th International Conference of the Immunology of Diabetes Society (IDS) -
JDRF Travel Scholarships
To apply for a JDRF Travel Scholarship, submit your abstract and scholarship application by March 1st. More information. Additionally, please visit the IDS website (http://www.ids2012.ca/) for more information on IDS 2012.
1/25/2012
Faculty Opportunity at The Benroya Research Institute
The Benaroya Research Institute, in Seattle WA, is recruiting an Assistant/Associate Professor with an MD, PhD, or MD/PhD degree whose research focuses on biomedical translational research. More information.
1/17/2012
Diabetic Complications Consortium (DCC) Pilot & Feasibility Opportunities 2012
The DCC is currently soliciting P&F proposals that advance the mission of the consortium.
Applications are due Thursday, May 17, 2012 for July start dates.
More information.
1/17/2012
The 4th International Conference on Stem Cells and Tissue Formation
July 18th – 20th, 2012
For more information, please visit: http://www.stemcellcongress-dresden.org/
1/9/2012
3rd Annual GNF-JDRF Diabetes Research Symposium
Wednesday, April 25th, 2012
8:30 AM – 5:00 PM
Registration is required – seating is limited.
For registration, please go to: http://www.gnf.org/collaborations/jdrf/symposium.htm
More information.
12/21/2011
FOCIS 2012 – JDRF Travel Awards for Young Investigators
JDRF will be offering travel awards to support the attendance of JDRF-supported young investigators at FOCIS 2012. This year, FOCIS will be held from June 21-24 in Vancouver, BC. Please visit http://www.focisnet.org/FOCIS/ for further details about the meeting.
Eligibility:
PI of a JDRF Training or Career Development Award: Postdoctoral Fellowship (PF), Advanced Postdoctoral Fellowship (APF)/Transition Award, Career Development Award (CDA), or Early Career Patient-oriented Diabetes Research Awards (ECPODRA), scientific lab member of a JDRF sponsored lab working directly on a JDRF sponsored project.
To apply:
Submit an abstract to FOCIS by the deadline of January 25, 2012.
Inform JDRF of your abstract submission and indicate the nature of your association with a specified JDRF grant (email to: elklein@jdrf.org)
Conditions of award:
Present your JDRF-sponsored research at the FOCIS 2012 meeting.
Notification:
The amount of the award is TBD, and may vary depending on your departure location.
Please be aware that the travel award amount may not cover the complete expenses related to the conference, and that supplementation from your JDRF grant or other sources may be necessary.
JDRF is pleased to continue this partnership with FOCIS in the support of young investigators. Should you have any questions, please contact Emily L. Klein at elklein@jdrf.org or Dr. Simi Ahmed at sahmed@jdrf.org.
12/5/2011
A Letter to all JDRF Investigators in Regards to the New JDRF Brand and Logo
We would like to share with you some exciting news about JDRF. Over the past year, JDRF has undertaken a process to evaluate the perception of our organization with our various stakeholders. This process has resulted in a number of evolutionary changes regarding how we speak about JDRF and regarding the images we use to represent JDRF. Read more
12/2/2011
The following NIDDK funding opportunity has a Detailed Budget Correction (PAR-11-349):
http://grants.nih.gov/grants/guide/notice-files/NOT-DK-12-005.html
11/30/2011
TEDDY releases RFP on Gene Expression
View the PDF for additional information
11/16/2011
NIDDK has launched a new RFA. Please see the following for more information:
Bioengineering Interdisciplinary Training and Education for Type I Diabetes Research (T90/R90)
Purpose: to promote the development of an interdisciplinary workforce for conducting bioengineering research to develop innovative technologies for treatment of type 1 diabetes including creating integrated long term glucose regulated insulin delivery systems (artificial pancreas), beta cell or islet encapsulation for beta cell replacement therapy, and/or beta cell and autoimmunity imaging methods. This FOA will support institutional training and education programs in type 1 diabetes research for postdoctoral level researchers with backgrounds in bioengineering and/or computational sciences.
LOI Due Date: February 14, 2012
Application Due Date: March 14, 2012
11/11/2011
Additional Research Opportunities to be considered by JDRF Canadian Clinical Trial Network (JDRF CCTN)
JDRF Canadian Clinical Trial Network (JDRF CCTN) is a platform for clinical research in Southern Ontario to test new treatments and technologies for type 1 diabetes. JDRF CCTN is pleased to explore all additional research opportunities that can be implemented using the JDRF CCTN structure. These opportunities may include partnerships with additional institutions, investigators, and industry.
More information and how to apply. Note that this opportunity is for Canadian applicants only.
RFI Due Date: 12/5/2011
11/10/2011
TEDDY releases RFP on Viral Metagenomics and Microbiome
View the PDF for additional information
11/6/2011
A number of NIDDK RFAs with upcoming deadlines are listed below. Please see the following for more information:
Small Business Innovation Research to Develop New Methods and Technologies able to Identify Individuals at Risk of Developing Type 1 Diabetes [T1D] (R43)
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-11-024.html
LOI Due Date: November 22, 2011
Application Due Date: December 22, 2011
Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas [(SBIR) (R43/R44)]
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-11-018.html
LOI Due Date: October 26, 2011
Application Due Date: November 23, 2011
Improving Adherence in Pre-teens, Adolescents and Young Adults with Type 1 Diabetes (DP3)
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-11-029.html
LOI Due Date: February 2, 2012
Application Due Date: March 2, 2012
Function of Type 1 Diabetes Genes (DP3)
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-11-019.html
LOI Due Date: February 1, 2012
Application Due Date: February 29, 2012
11/3/2011
TEDDY releases RFP on Dietary Biomarkers in T1D
View the PDF for additional information
10/31/2011
TEDDY releases RFP on Metabolomics in T1D
View the PDF for additional information
10/21/2011
Diabetes TrialNet Information for Research Collaborators
See the following link for additional information: http://www.diabetestrialnet.org/researchers/index.htm
10/21/2011
Euro-BioImaging Proof-of-Concept Studies: CALL for USERS open now! (Oct. 1st to Nov.15th, 2011)
10/21/2011
NIDDK funding opportunities are now active (note that the first two use the new Type 1 Diabetes Statutory Appropriation funding). See the following links for more information:
http://grants.nih.gov/grants/guide/pa-files/PAR-11-349.html
http://grants.nih.gov/grants/guide/pa-files/PAR-11-350.html
http://grants.nih.gov/grants/guide/pa-files/PAR-09-247.html